References
- WeiergräberMStephaniUKöhlingRVoltage-gated calcium channels in the etiopathogenesis and treatment of absence epilepsyBrain Res Rev20106224527120026356
- PanayiotopoulosCPTreatment of typical absence seizures and related epileptic syndromesPaediatr Drugs2001337940311393330
- HirschEThomasPPanayiotopolosCPChildhood and juvenile absence epilepsyEngelJPedleyTAEpilepsy: a comprehensive textbookSecond editionPhiladelphiaLippincott Williams & Wilkins200823972411
- GibbsFADavisHLennoxWGThe electroencephalogram in epilepsy and in conditions of impaired consciousnessArch Neurol Psychiatry19353411331148
- Commission on Classification and Terminology of the International League Against Epilepsy, 1981Proposal for revised clinical and electroencephalographic classification of epileptic seizuresEpilepsia1981224895016790275
- OnatFYvan LuijtelaarGNehligASneadOC3rdThe involvement of limbic structures in typical and atypical absence epilepsyEpilepsy Res201310311112322989853
- BergATBerkovicSFBrodieMJRevised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009Epilepsia2010567668520196795
- Commission on Classifcation and Terminology of the International League Against Epilepsy, 1989Proposal for revised classification of epilepsies and epileptic syndromesEpilepsia1989303893992502382
- CovanisAEyelid myoclonia and absenceAdv Neurol20059518519615508923
- BureauMTassinariCAEpilepsy with myoclonic absencesBrain Dev20052717818415737698
- GotmanJPittauFCombining EEG and fMRI in the study of epileptic dischargesEpilepsia201152Suppl 4S38S42
- ManningJPRichardsDABoweryNGPharmacology of absence epilepsyTrends Pharmacol Sci20032454252914559407
- PoolosNPHyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Ion Channelopathy in EpilepsyNoebelsJLAvoliMRogawskiMAOlsenRWDelgado-EscuetaAVJasper’s Basic Mechanisms of the Epilepsies [Internet]4th editionBethesda (MD)National Center for Biotechnology Information (US)2012
- DeransartCRibanVLêBMarescauxCDepaulisADopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the ratNeuroscience200010033534411008171
- RussoECitraroRDonatoGmTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsyNeuropharmacology201369253623092918
- CurrierRDKooiKASaidmanLJPrognosis of “pure” petit mal; a follow-up studyNeurology19631395996714079956
- ShorvonSWalkerMStatus epilepticus in idiopathic generalized epilepsyEpilepsia200546Suppl 9S73S79
- WirrellECCamfieldCSCamfieldPRDooleyJMGordonKESmithBLong-term psychosocial outcome in typical absence epilepsy. Sometimes a wolf in sheeps’ clothingArch Pediatr Adolesc Med19971511521589041870
- WirrellECCamfieldPRCamfieldCSDooleyJMGordonKEAccidental injury is a serious risk in children with typical absence epilepsyArch Neurol1996539299328815859
- MirskyMPrimacaDMarsanaCRosvoldaHStevensJA comparison of the psychological test performance of patients with focal and nonfocal epilepsyExp Neurol19602758914422879
- KilloryBDBaiXNegishiMImpaired attention and network connectivity in childhood absence epilepsyNeuroimage2011562209221721421063
- VegaCGuoJKilloryBSymptoms of anxiety and depression in childhood absence epilepsyEpilepsia2011527074
- GlauserTACnaanAShinnarSChildhood Absence Epilepsy Study TeamEthosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: Initial monotherapy outcomes at 12 monthsEpilepsia20135414115523167925
- van LuijtelaarGThe prevention of behavioral consequences of idiopathic generalized epilepsy: evidence from rodent modelsNeurosci Lett201149717718421354267
- RussoECitraroRScicchitanoFComparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsyEpilepsia2010511560156919919665
- BergaminiLBramSBrogliaSRiccioAL’insorgenza tardiva di crisi Grande Male nel Piccolo Male. Studio catamnestico di 78 casi. [Late onset grand mal seizures in pure petit mal epilepsy]Arch Suisses Neurol Neurochir Psychiatr196596306317 Italian
- GlauserTBen-MenachemEBourgeoisBILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromesEpilepsia2006471094112016886973
- NunesVDSawyerLNeilsonJSarriGCrossJHDiagnosis and management of the epilepsies in adults and children: summary of updated NICE guidanceBMJ2012344e28122282528
- CoulterDAHuguenardJRPrinceDASpecific petit mal anticonvulsants reduce calcium currents in thalamic neuronsNeurosci Lett19899874782710401
- ZimmermanFTBurgemeisterBBA new drug for petit mal epilepsyNeurology1958876977513590384
- CovanisASkiadasKLoliNLadaCTheodorouVAbsence epilepsy: early prognostic signsSeizure199212812891344778
- HwangHKimHKimSHLong-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsyBrain Dev20123434434821893390
- BrowneTRDreifussFEDykenPREthosuximide in the treatment of absence (petit mal) seizuresNeurology197525515524805382
- CarrazGFauRChateauRCommunication à propos des pemiers essais cliniques sur l’activité antiépileptique de l’acide n-dipropylacétique (sel de Na) [Communication about first clinical trials of n-dipropylacetic acid (Na salt) antiepileptic activity]Ann Med Psychol. (Paris)1964122577585 French14230742
- MarsonAGAl-KharusiAMAlwaidhMPRSANAD Study groupSANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialLancet20073691016102617382828
- WhiteHSRhoJMMechanisms of Action of Antiepileptic DrugsWest Islip, New YorkProfessional Communications, Inc2010
- VillarrealHJWilderBJWillmoreLJBaumanAWHammondEJBruniJEffect of valproic acid on spike and wave discharges in patients with absence seizuresNeurology19782888689199687
- ErenbergGRothnerADHenryCECruseRPValproic acid in the treatment of intractable absence seizures in children: a single-blind clinical and quantitative EEG studyAm J Dis Child19821365265296807081
- Lerman-SagieTWatembergNKramerUShaharELermanPAbsence seizures aggravated by valproic acidEpilepsia20014294194311488896
- FerrieCDRobinsonROKnottCPanayiotopoulosCPLamotrigine as an add-on drug in typical absence seizuresActa Neurol Scand1995912002027793236
- HosfordDAWangYUtility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizuresEpilepsia1997384084149118845
- CoppolaGLicciardiFSciscioNRussoFCarotenutoMPascottoALamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological studyBrain Dev200426262914729411
- HolmesGLFrankLMShethRDLamotrigine monotherapy for newly diagnosed typical absence seizures in childrenEpilepsy Res20088212413218778916
- FrankLMEnlowTHolmesGLLamictal (lamotrigine) monotherapy for typical absence seizures in childrenEpilepsia19994097397910403222
- GerickeCAPicardFde Saint-MartinAStrumiaSMarescauxCHirschEEfficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open studyEpileptic Disord1999115916510937148
- BuoniSGrossoSFoisALamotrigine in typical absence epilepsyBrain Dev19992130330610413016
- CallaghanNO’HareJO’DriscollDO’NeillBDalyMComparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal)Dev Med Child Neurol1982248308366818076
- MartinovicZComparison of ethosuximide with sodium valproate as monotherapies of absence seizuresParsonageMAdvances in Epileptology: 14th Epilepsy International SymposiumNew YorkRaven Press1983301305
- SatoSWhiteBGPenryJKDreifussFESackellaresJCKupferbergHJValproic acid versus ethosuximide in the treatment of absence seizuresNeurology1982321571636798490
- CoppolaGAuricchioGFedericoRCarotenutoMPascottoALamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group studyEpilepsia2004451049105315329068
- GlauserTACnaanAShinnarSChildhood Absence Epilepsy Study GroupEthosuximide, valproic acid, and lamotrigine in childhood absence epilepsyN Engl J Med201036279079920200383
- Canadian Clobazam Cooperative GroupClobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective studyEpilepsia1991324074162044502
- MikkelsenBBirket-SmithEBradtSClonazepam in the treatment of epilepsy. A controlled clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizuresArch Neurol197633322325817696
- SatoSWhiteBGPenryJKValproic acid versus ethosuximide in the treatment of absence seizuresNeurology1982321571636798490
- VerrottiACerminaraCDomizioSLevetiracetam in absence epilepsyDev Med Child Neurol20085085085318808424
- FattoreCBoniverCCapovillaGA multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsyEpilepsia20115280280921320119
- AuvinSChhunSBerquinPPonchelEDelanoëCChironCAggravation of absence seizure related to levetiracetamEur J Paediatr Neurol20111550851121680209
- CrossJHTopiramate monotherapy for childhood absence seizures: an open label pilot studySeizure20021140641012160672
- Piña-GarzaJESchwarzmanLWiegandFHulihanJPilot study of topiramate in childhood absence epilepsyActa Neurol Scand2011123545920219018
- YamauchiTAikawaHEfficacy of zonisamide: our experienceSeizure200413Suppl 1S41S4815511689
- WilfongASchultzRZonisamide for absence seizuresEpilepsy Res200564313415847848
- ShaharEMBrandNEffect of add-on amantadine therapy for refractory absence epilepsyJ Pediatr19921215 Pt 18198211432438
- PerryMSBaileyLJKotechaACMalikSIHernandezAWAmantadine for the treatment of refractory absence seizures in childrenPediatr Neurol20124624324522490771
- LombrosoCTForxytheIA long-term follow-up of acetazolamide (diamox) in the treatment of epilepsyEpilepsia1960149350014418080
- ChaoDHPlumbRLDiamox in epilepsy. A critical review of 178 caseJ Pediatr19615821121813692366
- PeruccaEGramLAvanziniGDulacOAntiepileptic drugs as a cause of worsening seizuresEpilepsia1998395179578007
- SomervilleERSome treatments cause seizure aggravation in idiopathic epilepsies (especially absence epilepsy)Epilepsia200950Suppl 8S31S36
- LiuLZhengTMorrisMJThe mechanism of carbamazepine aggravation of absence seizuresJ Pharmacol Exp Ther200631979079816895979
- ZhengTClarkeALMorrisMJReidCAPetrouSO’BrienTJOxcarbazepine, not its active metabolite, potentiates GABAA activation and aggravates absence seizuresEpilepsia200950838718717705
- SneadOC3rdHoseyLCExacerbation of seizures in children by carbamazepineN Engl J Med19853139169213929090
- HornCSAterSBHurstDLCarbamazepine-exacerbated epilepsy in children and adolescentsPediatr Neurol198623403453508708
- TalwarDAroraMSSherPKEEG changes and seizure exacerbation in young children treated with carbamazepineEpilepsia1994351541159
- CoenenAMBlezerEHvan LuijtelaarELEffects of the GABA-uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of ratsEpilepsy Res19952189947588592
- BouwmanBMSuffczynskiPMidzyanovskayaISMarisEvan den BroekPLvan RijnCMThe effects of vigabatrin on spike and wave discharges in WAG/Rij ratsEpilepsy Res200776344017643266
- ParkerAPAgathonikouARobinsonROPanayiotopoulosCPInappropriate use of carbamazepine and vigabatrin in typical absence seizuresDev Med Child Neurol1998405175199746003
- KnakeSHamerHMSchomburgUOertelWHRosenowFTiagabine-induced absence status in idiopathic generalized epilepsySeizure1999831431710486298
- LortieAChironCMumfordJDulacOThe potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrinNeurology19934311 Suppl 5S24S278232984
- YangMTLeeWTChuLWShenYZAnti-epileptic drugs-induced de novo absence seizuresBrain Dev200325515612536034
- SchmidtDGramLBrodieMTiagabine in the treatment of epilepsy – a clinical review with a guide for the prescribing physicianEpilepsy Res20004124525110962215
- KoeppMJEdwardsMCollinsJFarrelFSmithSStatus epilepticus and tiagabine therapy revisitedEpilepsia2005461625163216190934
- VintonAKornbergAJCowleyMMatkovicZKilpatrickCO’BrienTJTiagabine-induced generalised non convulsive status epilepticus in patients with lesional focal epilepsyJ Clin Neurosci20051212813315749411
- ZhuYVaughnBVNon-convulsive status epilepticus induced by tiagabine in a patient with pseudoseizureSeizure200211575911888262
- GentonPWhen antiepileptic drugs aggravate epilepsyBrain Dev200022758010722956
- OsorioIReedRCPeltzerJNRefractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepineEpilepsia20004188789410897162
- HigginsGABreysseNUndzysEComparative study of five antiepileptic drugs on a translational cognitive measure in the rat: relationship to antiepileptic propertyPsychopharmacology201020751352719841906
- BialerMJohannessenSILevyRHPeruccaETomsonTWhiteHSProgress report on new antiepileptic drugs: A summary of the Eleventh Eilat Conference (EILAT XI)Epilepsy Res201310323023219031
- LargeCHSokalDMNehligAThe spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical useEpilepsia20125342543622221318
- TrudeauVMyersSLaMoreauxLAnhutHGarofaloEEbersoleJGabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studiesJ Child Neurol1996114704759120226
- ArsovTMullenSADamianoJAEarly onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiencyEpilepsia201253204207
- NehligADufourFKlingerMWillingLBSimpsonIAVannucciSJThe ketogenic diet has no effect on the expression of spike-and-wave discharges and nutrient transporters in genetic absence epilepsy rats from StrasbourgJ Neurochem2009109Suppl 1S207S213
- GroomesLBPyzikPLTurnerZDorwardJLGoodeVHKossoffEHDo patients with absence epilepsy respond to ketogenic diets?J Child Neurol20112616016520647578
- DedeurwaerdereSVonckKClaeysPAcute vagus nerve stimulation does not suppress spike and wave discharges in genetic absence epilepsy rats from StrasbourgEpilepsy Res20045919119815246120
- KostovHLarssonPGRøsteGKIs vagus nerve stimulation a treatment option for patients with drug-resistant idiopathic generalized epilepsy?Acta Neurol Scand Suppl2007187555817419830
- AryaRGreinerHMLewisAVagus nerve stimulation for medically refractory absence epilepsySeizure201322426727023391567
- KwanPJohnsonMMerschhemkeMLuSAdjunctive brivaracetam in adults with uncontrolled generalized seizures: sub-population analysis of the results of a randomized, double-blind, placebo-controlled trialProceedings of the 64th annual meeting of the American Epilepsy SocietyDecember 3–7, 2010San Antonio, Texas Abstract 1.267
- HanHACortezMASneadOC3rdGABAB receptors in absence epilepsyEpilepsia201051Suppl 5S24
- NgombaRTSantoliniISaltTEMetabotropic glutamate receptors in the thalamocortical network: strategic targets for the treatment of absence epilepsyEpilepsia2011521211122221569017
- TringhamEPowellKLCainSMT-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizuresSci Transl Med20124121121ra19
- FarwellJRDodrillCBBatzelLWNeuropsychological abilities of children with epilepsyEpilepsia1985263954004043009
- BlumeWTLennox-Gastaut syndrome: potential mechanisms of cognitive regressionMent Retard Dev Disabil Res Rev20041015015315362174
- ShirasakaYLack of neuronal damage in atypical absence status epilepticusEpilepsia2002431498150112460251
- ChanKFJiaZMurphyPABurnhamWMCortezMASneadOC3rdLearning and memory impairment in rats with chronic atypical absence seizuresExp Neurol200419032833615530872
- ChanKFBurnhamWMJiaZCortezMASneadOC3rdGABAB receptor antagonism abolishes the learning impairments in rats with chronic atypical absence seizuresEur J Pharmacol2006541647216762340
- ArzimanoglouAFrenchJBlumeWTLennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodologyLancet Neurol20098829319081517
- BeaumanoirABlumeWThe Lennox-Gastaut syndromeEpileptic Syndromes in Infancy, Chidhood and Adolescence5th edRogerJBureauMDravetCGentonPTassinariCAWolfPLondonJohn Libbey200589114
- MotteJTrevathanEArvidssonJFBarreraMNMullensELManascoPLamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study GroupN Engl J Med1997337180718129400037
- GlauserTKlugerGSachdeoRKraussGPerdomoCArroyoSRufinamide for generalized seizures associated with Lennox-Gastaut syndromeNeurology2008701950195818401024
- SchmidtDBourgeoisBA risk-benefit assessment of therapies for Lennox-Gastaut syndromeDrug Saf20002246747710877040
- JeavonsPMClarkJEMaheshwariMCTreatment of generalized epilepsies of childhood and adolescence with sodium valproate (“epilim”)Dev Med Child Neurol197719925403104
- CovanisAGuptaAKJeavonsPMSodium valproate: monotherapy and polytherapyEpilepsia1982236937206816580
- TsudaYOguniHSakauchiMOsawaMAn electroclinical study of absence seizures in Dravet syndromeEpilepsy Res2013103889622824327
- NgYTConryJADrummondRStolleJWeinbergMAOV-1012 Study InvestigatorsRandomized, phase III study results of clobazam in Lennox-Gastaut syndromeNeurology2011771473148121956725
- DonaldsonJAGlauserTAOlberdingLSLamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome)Epilepsia19973868739024186
- TimmingsPLRichensALamotrigine as an add-on drug in the management of Lennox-Gastaut syndromeEur Neurol1992323053071490494
- GuerriniRDravetCGentonPBelmonteAKaminskaADulacOLamotrigine and seizure aggravation in severe myoclonic epilepsyEpilepsia1998395085129596203
- SachdeoRCGlauserTARitterFReifeRLimPPledgerGA double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study GroupNeurology1999521882188710371538
- De Los ReyesECSharpGBWilliamsJPHaleSELevetiracetam in the treatment of Lennox-Gastaut syndromePediatr Neurol20043025425615087103
- HuberBBömmelWHauserIEfficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilitiesSeizure20041316817515010054
- FarwellJRAndersonGDKerrBMTorJALevyRHStiripentol in atypical absence seizures in children: an open trialEpilepsia1993343053118453942
- ChironCMarchandMCTranAStiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study groupLancet20003561638164211089822
- BurdetteDESackellaresJCFelbamate pharmacology and use in epilepsyClin Neuropharmacol1994173894029316688
- JensenPKFelbamate in the treatment of Lennox-Gastaut syndromeEpilepsia199435Suppl 5S54S578039473
- LeeYJKangHCSeoJHLeeJSKimHDEfficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsyBrain Dev20103220821119304420
- IinumaKHaginoyaKClinical efficacy of zonisamide in childhood epilepsy after long-term treatment: a postmarketing, multi-institutional surveySeizure200413Suppl 1S34S3915511687
- LermanPSeizures induced or aggravated by anticonvulsantsEpilepsia1986277067103780607
- VosslerDGExacerbation of seizures in Lennox-Gastaut syndrome by gabapentinNeurology1996468528538618710
- LemmonMETeraoNNNgYTReisigWRubensteinJEKossoffEHEfficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution’s experience and summary of the literatureDev Med Child Neurol20125446446822443637
- FrostMGatesJHelmersSLVagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndromeEpilepsia2001421148115211580762
- CersósimoROBartuluchiMFortiniSSoraruAPomataHCaraballoRHVagus nerve stimulation: effectiveness and tolerability in 64 paediatric patients with refractory epilepsiesEpileptic Disord20111338238822258042
- FerrieCDAgathonikouAParkerARobinsonROPanayiotopoulosCPThe spectrum of childhood epilepsies with eyelid myocloniaDuncanJSPanayiotopoulosCPEyelid Myoclonia with AbsencesLondonLibbey19963948
- StrianoPSofiaVCapovillaGA pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome)Epilepsia20084942543018248445
- WallaceSJMyoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamideEpilepsy Res1998291471549477147
- ManonmaniVWallaceSJEpilepsy with myoclonic absencesArch Dis Child1994702882908185360
- LabateAColosimoEGambardellaALeggioUAmbrosioRQuattroneALevetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label studySeizure20061521421816420982
- HäuslerMKlugerGNikanorovaMEpilepsy with myoclonic absences – favourable response to add-on rufinamide treatment in 3 casesNeuropediatrics201142282921557146